CD47 and melanoma: Our results demonstrate that in both freshly resected melanoma samples, as well as, in melanoma patient-derived cell lines, the DNA region corresponding to the CD47 promoter has a significantly increased chromatin accessibility which could be conjectured as a sign of active mRNA transcription (Figure 2A).